Search Within

Steven Maron

  1. "Heiko Schoder"
Formats
  1. Journal Article (4)
  2. Meeting Abstract (3)
Groups
  1. Center for Pancreatic Cancer Research (7)
  2. Department of Medicine (7)
  3. GSK Faculty (7)
  4. Gastrointestinal Oncology Service (7)
  5. Graduate Medical Education (7)
  6. Molecular Imaging and Therapy Service (7)

More Groups

People
  1. Heiko Schoder (7)
  2. Yelena Janjigian (7)
  3. Laura Tang (5)
  4. Geoffrey Ku (4)
  5. Jason Lewis (4)
  6. Neeta Pandit-Taskar (4)

More People

Years
  1. 2025 (1)
  2. 2024 (3)
  3. 2023 (2)
  4. 2021 (1)
Publications
  1. Journal of Clinical Oncology (2)
  2. Journal of Nuclear Medicine (2)
  3. Annals of Surgical Oncology (1)
  4. European Journal of Surgical Oncology (1)
  5. Gastric Cancer (1)
Publishers
  1. American Society of Clinical Oncology (2)
  2. Society of Nuclear Medicine (2)
  3. Springer (2)
  4. Elsevier Inc. (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • PET-CT-based host metabolic (PETMet) features are associated with pathologic response in gastroesophageal adenocarcinoma
    Journal Article

    White, C.; Jayaprakasam, V. S.; Tenet, M.; Tang, L. H.; Schattner, M. A.; Janjigian, Y. Y.; Maron, S. B.; Schöder, H.; Larson, S. M.; Gönen, M.; more...
    European Journal of Surgical Oncology (2025)

    Fulltext@MSK | Save
  • Noninvasive assessment of programmed-death ligand-1 (PD-L1) in esophagogastric (EG) cancer using (18)F-BMS-986229 PET
    Meeting Abstract

    Cytryn, S. L.; Pandit-Taskar, N.; Maron, S. B.; Gu, P.; Ku, G. Y.; Chou, J. F.; Capanu, M.; Feder, L.; Philemond, S.; Lyashchenko, S. K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • (18)F-BMS-986229 PET to assess programmed-death ligand 1 status in gastroesophageal cancer
    Journal Article

    Cytryn, S. L.; Pandit-Taskar, N.; Lumish, M. A.; Maron, S. B.; Gu, P.; Ku, G. Y.; Chou, J. F.; Capanu, M.; Antoine, A.; Loegel, D.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Patient metabolic profile defined by liver and muscle (18)F-FDG PET avidity is independently associated with overall survival in gastric cancer
    Journal Article

    Vitiello, G. A.; Jayaprakasam, V. S.; Tang, L. H.; Schattner, M. A.; Janjigian, Y. Y.; Ku, G. Y.; Maron, S. B.; Schoder, H.; Larson, S. M.; Gönen, M.; more...
    Gastric Cancer (2024)

    Fulltext@MSK | Save
  • Patient metabolic profiles defined by liver and muscle 18F-FDG PET avidity are independently associated with overall survival in gastric cancer
    Meeting Abstract

    Vitiello, G. A.; Jayaprakasam, V. S.; Tang, L.; Schattner, M.; Janjigian, Y.; Ku, G.; Maron, S.; Schoder, H.; Larson, S.; Gonen, M.; more...
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Noninvasive assessment of human epidermal growth factor receptor 2 (HER2) in esophagogastric cancer using (89)Zr-trastuzumab PET: A pilot study
    Journal Article

    Lumish, M. A.; Maron, S. B.; Paroder, V.; Chou, J. F.; Capanu, M.; Philemond, S.; O'Donoghue, J. A.; Schoder, H.; Lewis, J. S.; Lyashchenko, S. K.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Imaging HER2-positive metastatic esophagogastric cancer with (89)Zr-trastuzumab PET and (18)F-FDG PET
    Meeting Abstract

    Lumish, M. A.; Maron, S. B.; Paroder, V.; Philemond, S.; O'Donoghue, J. A.; Schoder, H.; Lewis, J. S.; Janjigian, Y. Y.; Pandit-Taskar, N.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save